Notably, in a Drosophila melanogaster HD model, the KMO inhibitors reduce neuronal loss and prevent neurodegeneration, suggesting the therapeutic potential of targeting KMO in HD (Zhang et al., 2019). This evidence concerns the gene KMO and Huntington disease.